Bentham Science Logo

Track Your Manuscript:


Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 20, 10 Issues, 2020
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Endocrine, Metabolic & Immune Disorders - Drug Targets, Volume 6 - Number 3





Drug Targets to Pro-Angiogenetic Factors with Special Reference to Primary Peritoneal Mesothelioma

, 6(3): 271 - 277

Girolamo Ranieri, Eustachio Ruggieri, Gaetano Falco, Nicola Zizzo, Eliseo Mattioli, Alfredo Francesco Zito, Rosa Patruno and Giampietro Gasparini


DOI: 10.2174/187153006778250028



Origin and Biological Significance of Shed-Membrane Microparticles

, 6(3): 287 - 294

A. Tesse, M. C. Martinez, F. Meziani, B. Hugel, M. A. Panaro, V. Mitolo, J.-M. Freyssinet and R. Andriantsitohaina


DOI: 10.2174/187153006778249976




Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
(Italy)

Biography
View Full Editorial Board

COPE Compliant

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.
Scopus CiteScore Metrics: 1.79

Society Accreditations



Society Name: The official Journal of Associazione Medici Endocrinologi


Advertisement

How to write and publish your papers in high impact journalsCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog